Can vigorous exercise rewire diabetes risk after pregnancy?

NCT ID NCT07843082

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 25, 2026 ยท Last updated Sep 25, 2026

Summary

Researchers are testing whether eight weeks of supervised vigorous exercise improves insulin sensitivity in South Asian and Nordic women who had gestational diabetes. Participants complete four weekly sessions: two whole-body resistance workouts and two high-intensity interval cycling sessions. The study measures changes in how well the body clears glucose and uses insulin, along with fitness, strength, and body composition, to see if the response differs between the two groups.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
supervised vigorous exercise: resistance training plus high-intensity interval cycling
What this could lead to
If it works, this could show that a short, structured exercise program helps reverse early insulin resistance in women who had gestational diabetes, especially South Asian women at higher risk.
What could go wrong
The study is small, with 43 participants, and lasts only eight weeks, so any improvements may not last or may not apply to other groups. Exercise carries a low risk of muscle soreness or injury.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

43 people

The number who actually took part.

Started

Oct 2024

Finished

Sep 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Woman aged 18 years or older * Previous gestational diabetes * South Asian or Nordic origin, with both parents of the same ethnic background Exclusion Criteria: * Habitual physical activity above national recommendations (more than 75 minutes of vigorous exercise per week) at inclusion * Known type 1 or type 2 diabetes * Use of glucose-lowering medication, or other drugs known to interfere with glucose or lipid metabolism or with the response to exercise * Pregnancy * Liver, renal, cardiopulmonary, oncological or other debilitating disease that could jeopardise participant safety or compliance with the protocol

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diabetes are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Aker sykehus

    Oslo, Norway

More trials for these conditions

Other studies related to the condition(s) this trial covers.